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Abstract
Background: Generation of large quantities of endothelial cells is highly desirable for vascular research, for the
treatment of ischemia diseases, and for tissue regeneration. To achieve this goal, we developed a simple, chemically
defined culture system to efficiently and rapidly differentiate endothelial cells from human pluripotent stem cells by
going through an MESP1 mesoderm progenitor stage.
Methods: Mesp1 is a key transcription factor that regulates the development of early cardiovascular tissue. Using
an MESP1-mTomato knock-in reporter human embryonic stem cell line, we compared the gene expression profiles
of MESP1+ and MESP1− cells and identified new signaling pathways that may promote endothelial differentiation.
We also used a 3D scaffold to mimic the in vivo microenvironment to further improve the efficiency of endothelial
cell generation. Finally, we performed cell transplantation into a critical limb ischemia mouse model to test the
repairing potential of endothelial-primed MESP1+ cells.
Results: MESP1+ mesoderm progenitors, but not MESP1− cells, have strong endothelial differentiation potential. Global
gene expression analysis revealed that transcription factors essential for early endothelial differentiation were enriched
in MESP1+ cells. Interestingly, MESP1 cells highly expressed Sphingosine-1-phosphate (S1P) receptor and the addition
of S1P significantly increased the endothelial differentiation efficiency. Upon seeding in a novel 3D microniche
and priming with VEGF and bFGF, MESP1+ cells markedly upregulated genes related to vessel development and
regeneration. 3D microniches also enabled long-term endothelial differentiation and proliferation from MESP1+
cells with minimal medium supplements. Finally, we showed that transplanting a small number of endothelial-primed
MESP1+ cells in 3D microniches was sufficient to mediate rapid repair of a mouse model of critical limb ischemia.
Conclusions: Our study demonstrates that combining MESP1+ mesoderm progenitor cells with tissue-engineered
3D microniche and a chemically defined endothelial induction medium is a promising route to maximizing the
production of endothelial cells in vitro and augment their regenerative power in vivo.
Keywords: Human pluripotent stem cells, Endothelial cells, MESP1, 3D culture, Vascularization
* Correspondence: jie.na@tsinghua.edu.cn
1Center for Stem Cell Biology and Regenerative Medicine, School of
Medicine, Tsinghua University, Beijing 100084, China
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhang et al. Stem Cell Research & Therapy  (2017) 8:6 
DOI 10.1186/s13287-016-0455-4
Background
Human pluripotent stem cells (hPSCs) can self-renew
indefinitely and differentiate into all types of tissues in
the body. Therefore, it can be an unlimited source to
provide specialized cells for biomedical research and
cell-based therapy. hPSC-derived endothelial cells (ECs)
may be used to study angiogenesis and regenerate blood
vessels in ischemic diseases [1, 2]. Two methods of
endothelial differentiation have been developed. One
protocol uses embryoid bodies (EBs) as a differentiation
intermediate, followed by EC purification using specific
surface antibodies [1, 2]. As the cell types in EBs are
highly heterogeneous, the differentiation efficiency of
this protocol is relatively low. The second protocol was
developed more recently, where, a monolayer culture
and sometimes chemically defined conditions are used
to achieve directed and more efficient EC differenti-
ation. hPSCs are first induced to form mesoderm, then
vascular endothelial growth factor (VEGF) and basic
fibroblast growth factor (bFGF) are added to specify the
endothelial fate [3–7]. Such monolayer and serum-free
protocols can be modified to screen for small molecules
that may enhance differentiation and are more compat-
ible with requirements for clinical applications. The re-
ported yields of ECs range from 20 to 80%, depending
on the time period of differentiation and whether selec-
tion and purification steps were included in the proto-
col [3–7].
To achieve efficient in vitro differentiation and obtain
cells more closely resembling in vivo counterparts, it is
important to follow the developmental principle of the
desired lineage. During embryo development, a sub-
group of extraembryonic mesoderm cells forms primitive
endothelial cells in the yolk sac [8]. Mesoderm posterior
1 (Mesp1) is a basic helix–loop–helix (bHLH) transcrip-
tion factor first expressed in the nascent mesoderm dur-
ing gastrulation [9, 10]. These cells then migrate laterally
and anteriorly and give rise to the heart and great vessels
[9, 10]. In addition, Mesp1 progenies also contribute to
extraembryonic mesoderm [9]. The fate of this subgroup
of cells is less well studied. Studies in mice and zebrafish
convincingly demonstrated that Mesp1 represents the
earliest marker of cardiovascular progenitors [9, 11, 12].
However, whether MESP1 progenitor cells can be a good
source to generate ECs during hPSC in vitro differenti-
ation is unknown.
Previously, we generated an MESP1 reporter human
embryonic stem cell (hESC) line with mTomato
knocked in just before the stop code of the MESP1 cod-
ing sequence (manuscript submitted). In the latter
study, we showed that in mouse embryos, Mesp1 pro-
geny cells gave rise to vasculature in the yolk sac of the
mouse embryo. In hPSCs, MESP1-mTomato+ cells
could differentiate to ECs at high efficiency. Moreover,
plating MESP1+ cells in three-dimensional (3D) micro-
niches significantly improved the EC differentiation
efficiency and the long-term survival ability, and it fa-
cilitated cell transplantation repair of a critical limb is-
chemia mouse model. A global gene expression study
revealed novel genes and pathways that might regulate
EC differentiation and proliferation during the meso-
derm induction and endothelial fate specification
stages. Our work suggests that following developmental
cues and using 3D microniches that resemble the in
vivo cellular microenvironment may greatly facilitate
directed differentiation from hPSCs and augment the
repairing power of transplanted cells.
Methods
hPSC culture
H9 hESCs (WiCell Institute Inc., Madison, WI, USA),
H9-MESP1-mTomato hESC reporter cell line (gener-
ated by LW), and human induced pluripotent stem
cells (hiPSCs) (CD34-iPSCs, generated by FD) were
routinely maintained on MEF feeders in the hESC
medium: KnockOut Dulbecco’s modified Eagle’s
medium (DMEM) culture medium supplemented with
20% (vol/vol) KnockOut serum replacement, 1% non-
essential amino acids, 1 mM L-GlutaMAX-I, 0.1 mM
β-mercaptoethanol, and 8 ng/ml bFGF. They were
passaged with 1 mg/ml collagenase IV (Invitrogen,
Carlsbad, CA, USA) and seeded onto a 25 cm2 flask
that had been previously coated with 0.1% gelatin so-
lution (Sigma-Aldrich, St. Louis, MO, USA). To
achieve feeder-free culture, hESCs were maintained on
Matrigel (BD Biosciences, San Jose, CA, USA)-coated
plates (Corning, Corning, NY, USA) in E8 medium
(Stemcell Technologies, Vancouver, Canada).
Generation of MESP1-mTomato knocking-in reporter cell line
The homologous recombination donor vector was com-
posed of the MESP1 left arm, T2A fused with a
membrane-bound tdTomato (mTomato), PGK promoter-
driving puromycin resistance gene (PGK-Puro), MESP1
right arm, and MC-1 promoter-driving TK gene. H9 cells
were electroporated with TALEN and donor vectors by
Neon microporator (Invitrogen). After puromycin selec-
tion, targeted clones were picked and expanded for
characterization. Detailed protocols (design of TALEN
pair and synthesis of tandem arrays of TALE repeats) have
been described elsewhere (manuscript submitted).
RNA isolation, Q-PCR and high-throughput RNA sequencing
Total RNA was isolated from undifferentiated hESCs,
differentiation day 3 cells, and differentiation day 8 cells
on two-dimensional (2D) plates and 3D microniches
using RNeasy Plus Mini Kit (Qiagen, Hilden, Germany)
and treated with RNase-free DNase. 1 μg RNA of each
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sample was reverse-transcribed with Superscript III
(TransGen Biotech, Beijing, China). Quantitative real-
time polymerase chain reaction (Q-PCR) reactions were
performed using GoTaq qPCR Master Mix (Promega,
Madison, WI, USA) in a CFX96 Real-Time System (Bio-
Rad, Hercules, CA, USA) and results were analyzed with
the Bio-Rad CFX Manager program. The sample input
was normalized against the Ct (critical threshold) value of
GAPDH. Primer sequences are listed in Additional file 1:
Table S1. For high-throughput RNA sequencing, comple-
mentary DNA (cDNA) libraries were prepared using the
TruSeq™ RNA Sample Preparation kit (Illumina, San
Diego, CA, USA) and sequencing was performed at the
Biopic sequencing facility of Peking University (http://
biopic.pku.edu.cn/english/). The clean reads were
mapped to human reference genome (hg19) using
BWA software. Cluster analysis of gene expression pat-
terns was performed using Cluster 3.0 and JavaTreeview
software. Gene ontology (GO) term enrichment was ana-
lyzed using the database for annotation, visualization, and
integrated discovery (DAVID) (https://david.ncifcrf.gov).
Data are publicly available at the National Center for Bio-
technology Information with Gene Expression Omnibus
(GEO), accession number GSE79470.
MESP1+ mesoderm progenitor induction
MESP1+ mesoderm progenitor induction was performed
based on the method described by Cao et al. [13] with
some modifications. Briefly, undifferentiated hESCs cul-
tured in E8 medium were digested into single cells by
Accutase (EMD Millipore, Billerica, MA, USA) and
plated onto Matrigel-coated culture dishes at a density
of 6 × 104 cells/cm2 in a medium containing DMEM/
F12, 1 × B27 supplement (without vitamin A), 1% L-
GlutaMAX-I, 50 μg/ml ascorbic acid (Sigma-Aldrich),
induced by 25 ng/ml bone morphogenetic protein
(BMP)4 and 10 μM GSK3 inhibitor CHIR99021 (Tocris
Bioscience, Bristol, UK) for H9 and induced by 2 μM
CHIR99021 for CD34-iPSC. Rho-associated coiled-coil
kinase (ROCK) inhibitor Y27632 (Tocris Bioscience)
(5 μM) was added during cell dissociation and replating
for 24 h and it was removed during the medium
change. The monolayer-cultivated cells were harvested
at differentiation day 3 for further analysis.
Differentiation of MESP1+ cells to endothelial cells in 2D
culture system and 3D microniches
Day 3 MESP1+ cells were dissociated with Accutase for
10 min and plated onto Matrigel-coated culture dishes
at a density of 2 × 104 cells/cm2 in a basal medium and
stimulated with 25 ng/ml VEGF plus 10 ng/ml bFGF
(both Sino Biological, Inc., Beijing, China) for 5 d. For
the 3D microniches culture, biodegradable gelatin
microcryogels (GMs) were prepared using a microstencil
array chip as previously described [14]. Briefly, 6%
(wt/vol) gelatin precursor solution was mixed with
0.3% glutaraldehyde, and then 200 μl of precursor so-
lution was pipetted and scraped onto the microstencil
array chip. The microstencil array chip underwent
cryogelation for 16 h and was then lyophilized for
30 min (Beijing Boyikang Laboratory Instruments,
Beijing, China). GMs were then harvested by a
PMMA Ejector Pin array fabricated with a desktop
3D milling machine (MDX-40A; Roland DG,
Shizuoka-ken, Japan). Before loading the cells, the
harvested and dried GMs in the dish were sterilized
by an ethylene oxide sterilization system that per-
formed a 12 h degassing step under vacuum after
12 h of gas exposure (AN74j/Anprolene; Anderson
Products, Haw River, NC, USA) [15]. A 50 μl MESP1
+ cell suspension (1 × 107 cells/ml) was subsequently
pipetted onto 500 tightly packed GMs and automatic-
ally absorbed to hydrate the porous structures and
then maintained in a humidified chamber and incu-
bated at 37 °C for 2 h to allow cell attachment. Sub-
sequently, the basal medium supplemented with
25 ng/ml VEGF plus 10 ng/ml bFGF was added for
long-term culture.
FACS analysis
Cells were dissociated into single cells as described be-
fore, and resuspended in a FACS washing buffer (PBS
with 5% fetal calf serum (FCS) and 2.5 mM EDTA). To
perform direct flow cytometry, the samples were then
stained for FITC-conjugated CD31 (1:20; Miltenyi Bio-
tec, Bergisch Gladbach, Germany), and FITC-conjugated
mouse IgG2a (for CD31, 1:20; Miltenyi Biotec) was used
as isotype-matched negative control. Data were collected
with a FACSCaliber flow cytometer (BD Biosciences)
and analyzed using FlowJo software (Tree Star, Inc.,
Ashland, OR, USA).
Immunostaining analysis
Cells were fixed with 4% paraformaldehyde, perme-
abilized in 0.5% Triton X-100 (Sigma-Aldrich), blocked
in 10% normal goat serum (Origene, Rockville, MD,
USA), and then incubated with primary antibodies
against MESP1 (1:200; Abcam, Cambridge, MA, USA),
CD31 (1:100; Santa Cruz Biotechnology, Dallas, TX,
USA), VE-cadherin (1:200; Abcam), αSMA (1:200;
Abcam), human nuclei antibody (1:100; Abcam) in 4 °C
overnight and detected by DyLight 488- or 549-conjugated
secondary antibodies (Thermo Fisher Scientific, Waltham,
MA, USA). Nuclei were stained with 4′, 6-diamidino-2-
phenylindole (DAPI) (Sigma-Aldrich). A Nikon (Tokyo,
Japan) Ti-U fluorescence microscope was used for
image acquisition.
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hPSC-EC functional studies
The biological function of hPSC-ECs was assessed by
DiI-conjugated acetylated low-density lipoprotein
(DiI-ac-LDL) uptake and vascular tube formation. For
the DiI-ac-LDL uptake assay, hPSC-ECs were incu-
bated with 20 mg/ml of DiI-Ac-LDL (Yeasen Biotech,
Hong Kong) at 37 °C for 6 h, washed with PBS, and
stained with Hoechst 33258 (Dojindo Kumamoto,
Japan). For the vascular tube formation assay, 1 × 105
cells were plated into one well of 24-well plates pre-
coated with Matrigel (BD Biosciences) and incubated
at 37 °C for 12 h.
Mouse model of hind limb ischemia fluorescence imaging
Procedures were performed on female BALB/c nude
mice (20–25 g; 8–10 weeks) as previously described [16]
with the approval from the Internal Review Board, La-
boratory Animal Research Center, Tsinghua University.
Unilateral left hind limb ischemia in mice was induced
by ligating the proximal end of the femoral artery and its
branches using 5-0 silk surgical suture as described in
[14]. The overlying skin was then closed by 5-0 silk sur-
gical suture. Cell transplantation was performed after
skin closure. 300 medium-soaked GMs (acellular con-
trols) or 300 cell-load GMs (3 × 105 cells) were washed
with PBS, then resuspended in 300 μl gelatin solution
and intramuscularly injected into three sites of the graci-
lis muscle around the artery incision using 1 ml syringes
with a 23-gauge needle. For free cell injection, 1 × 107
cells were mixed with Matrigel and injected as above.
Blood perfusion analysis was performed after surgery
at the indicated days post operation on a home-made
fluorescence imaging system [17] in reflectance geom-
etry. Animals were injected with indocyanine green
(ICG, 0.1 ml of 100 μg/ml) through the tail vein and
time-series fluorescence images were collected for
100 min at intervals of 0.2 s.
Statistical analysis
Quantitative data are expressed as mean ± standard devi-
ation. The statistical significance was determined using a
Student’s t test (two-tailed) for two groups or one-way
ANOVA for multiple groups. A value of p < 0.05 was
considered statistically significant.
Results
MESP1 reporter marked cardiovascular progenitor cells
Mesp1 is a master regulator of early heart development
[9, 11, 18]. Using mouse embryos from Mesp1cre/+
crossed with ROSA26Sortm4(ACTB-tdTomato,-EGFP)Luo, we
found that in addition to the heart, Mesp1 progenies
(marked by GFP) also formed yolk sac blood vessels,
suggesting that a subgroup of Mesp1 cells may have
strong endothelial differentiation potential given the
appropriate induction cues (Fig. 1a). To study MESP1
cells during endothelial differentiation in the human sys-
tem, we generated an MESP1-mTomato reporter hESC
line through TALEN-mediated homologous recombin-
ation, which enabled us to monitor and purify MESP1-
expressing mesoderm progenitor cells (Fig. 1b; manuscript
submitted).
MESP1-mTomato reporter cells do not show any
fluorescence in undifferentiated hESCs cultured in E8
medium, but strongly turned on red fluorescence in re-
sponse to BMP4 and increasing concentrations of
CHIR99021 (a small molecule inhibitor of GSK3 and
activator of canonical Wnt signaling) treatment (Fig. 1c
and d). We could obtain nearly 100% MESP1-mTomato-
positive cells by treating cells with a combination of
BMP4 (25 ng/ml) and glycogen synthase kinase 3
(GSK3) inhibitor CHIR99021 (8–10 μM) in a chem-
ically defined medium consisting of DMEM/F12 and
B27(-VitA) supplement (Fig. 1c and d). To obtain a
homogeneous population of MESP1+ cells, undifferenti-
ated cells cultured in E8 without feeders were dissoci-
ated into single cells in the presence of Rho-associated
coiled-coil kinase (ROCK) inhibitor Y27632, replated
on Matrigel and then treated with BMP4 (25 ng/ml)
and CHIR99021 (10 μM). By day 3, FACS analysis
showed that most cells were positive for mTomato
(Fig. 1e). We also examined the expression of mesoder-
mal and cardiac lineage marker genes by Q-PCR.
MESP1+ cells significantly upregulated mesoderm tran-
scription factors T/BRACHYURY (T), MESP1, and
GATA4, as well as early cardiac markers TBX5 and
NKX2.5. In contrast, the expression of pluripotency,
endoderm and neuroectoderm marker genes, OCT4,
SOX2, NANOG, SOX17, and PAX6 were significantly
downregulated in MESP1+ cells (Fig. 1f ). Immunostain-
ing confirmed that mTomato-positive cells co-localized
with endogenous MESP1 protein detected by an anti-
MESP1 antibody (Fig. 1g). Taken together, MESP1-
mTomato reporter cells reflected the expression of
endogenous MESP1 and exhibited gene expression typ-
ical of early cardiovascular progenitor cells.
Next, we performed high-throughput RNA sequencing
of MESP1-mTomato positive cells (MESP1+) at day 3 of
differentiation and compared their gene expression pro-
file with MESP1-mTomato negative cells (MESP1–) and
undifferentiated hESCs (Fig. 2a). A total of 1951 genes
showed a greater than 1.5-fold increase in MESP1-
mTomato+ versus undifferentiated hESCs, which were
grouped into seven clusters based on different dynamic
patterns in undifferentiated hESCs, MESP1+, and
MESP1– cells (Fig. 2b). Gene ontology (GO) analysis
showed that clusters 1, 2, 3, and 5 (upregulated in
MESP1+ compared with undifferentiated hESCs or
MESP1–) were enriched for genes involved in embryonic
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organ development, anterior/posterior pattern specifica-
tion, growth factor activity, and embryonic morphogen-
esis, respectively, which is in accordance with MESP1
functions during embryo development in vivo (Fig. 2b
and Additional file 2: Table S2 and Additional file 3:
Table S3). A total of 1596 genes in MESP1+ cells showed
more than 1.5-fold decrease compared to undifferenti-
ated hESCs and they were divided into five clusters
Fig. 1 Generation of MESP1+ cells from human embryonic stem cells. a Mesp1 progeny cells formed yolk sac blood vessels. Images of Mesp1
lineage cells (green) on the yolk sac of E9.5 embryos of Mesp1cre/+/ROSA26Sor tm4(ACTB-tdTomato,-EGFP)Luo genetic background. b Image showing
MESP1-mTomato knock-in reporter cells. c Protocol to derive MESP1+ cells from hESCs by treatment with BMP4 and CHIR99021. d Percentage of
MESP1+ cells on day 3 under different induction conditions (n = 3, ****p < 0.0001.). e FACS analysis showing, on day 3, that 97.93% of cells turned
on MESP1-mTomato after treatment with BMP4 (25 ng/ml) and CHIR (10 μM). f Q-PCR analysis showing the downregulation of pluripotency,
endoderm and ectoderm marker genes, and upregulation of mesoderm and cardiac markers genes in MESP1+ cells vs. MESP– cells (n = 3).
g MESP1-mTomato reporter expression co-localized with anti-MESP1 antibody (arrowheads). Scale bars: 100 μm
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Fig. 2 High-throughput RNA sequencing analysis of MESP1-mTomato mesoderm progenitor cells. a Flow chart of MESP1-mTomato cell gene
expression analysis. b and c Genes upregulated and downregulated in MESP1-mTomato+ cells compared with hESCs (fold change > 1.5). They
were divided into different groups based on their FPKM values in hESC, MESP1-mTomato+, and MESP1-mTomato– cells. The number of genes
in each group, the top GO term, and the enrichment p values are listed. d Q-PCR validation of key genes enriched in MESP1+ cells according
to the RNA-seq result (n = 3, *p < 0.05, **p < 0.005, ***p < 0.001, MESP1+ versus MESP1–; t test)
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according to their different dynamic patterns (Fig. 2c
and Additional file 2: Table S2 and Additional file 3:
Table S3). GO analysis showed that clusters 4 and 5 were
closely related to neural differentiation, which reflects that
the one important aspect of mesoderm induction is to in-
hibit neural fate [19]. Interestingly, the expression of genes
involved in the plasma membrane and biological adhesion
obviously decreased. This is in agreement with the meso-
derm differentiation process that involves an epithelial-to-
mesenchymal transition and dramatic downregulation of
cell–cell adhesion and selected extracellular matrix (ECM)
genes [18]. Genes important for EC differentiation such as
TAL1, GATA2, RUNX1, HOXB4, CXCR4, KDR, CD34,
ETV2, HOXA9, and FOXC1 were among the most signifi-
cantly upregulated genes in MESP1-mTomato+ cells, as
confirmed by Q-PCR analysis (Fig. 2d).
Sphingosine-1-phosphate significantly enhanced CD31
endothelial differentiation
To test whether MESP1-mTomato+ cells have stronger
endothelial differentiation potential, we used a mono-
layer, serum-free, and chemically defined differentiation
system as shown in Fig. 3a. Sorted MESP1+ and MESP1–
were replated on Matrigel, and VEGF (50 ng/ml) and
Fig. 3 S1P greatly enhanced CD31 expression and upregulated endothelial marker genes expression. a Protocol for endothelial differentiation.
b MESP1+ cells have significantly greater ability to differentiate to endothelial cells compared with MESP1– cells. c Q-PCR analysis of S1P receptor
expression in undifferentiated hESC, differentiation day 3 MESP1-mTomato– (MESP1–) and MESP1-mTomato+ cells (MESP1+). d Immunostaining analysis
showing that S1P treatment greatly enhanced the generation of CD31+ cells on differentiation day 8. Scale bars: 100 μm. e Quantification of
FACS analysis of CD31+ cells percentage after S1P treatment on differentiation day 8 (n = 3, ****p < 0.0001). f Q-PCR analysis showing S1P treatment
significantly upregulated endothelial marker genes expression (n = 3)
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bFGF (10 ng/ml) were added. After 5 days, cells were
harvested for FACS analysis of endothelial cell surface
marker CD31 expression. Some 18.5% of MESP1+ sorted
cells expressed CD31 compared to only 1.5% from
MESP1– cells (Fig. 3b). This result suggested that, as in
the embryo, MESP1+ cells indeed had stronger endothe-
lial differentiation potential. From our RNA-seq data, we
found that Sphingosine-1-phosphate receptor 3 (S1PR3),
but not S1PR1 and S1PR2, was significantly upregulated
in MESP1+ cells. Q-PCR analysis confirmed the expres-
sion patterns of S1PR1, S1PR2, and S1PR3. S1PR3 was
nearly 15-fold higher in MESP1+ cells compared with
hESCs and MESP1– (Fig. 3c). We next wanted to deter-
mine whether Sphingosine-1-phosphate (S1P) treatment
could also affect hPSC endothelial differentiation. S1P
was added during day 3–8 of differentiation, together
with VEGF and bFGF. Immunostaining and FACS ana-
lysis showed that S1P greatly enhanced CD31 expres-
sion. Without S1P, CD31 was detected on 13.5% of cells,
while after treatment with 2 μM of S1P, 41.6% of cells
expressed CD31 (Fig. 3d and e). In addition, Q-PCR ana-
lysis showed that S1P treatment significantly upregulated
endothelial marker genes, including TAL1, CDH5, ID1,
FLT1, FOXC1, and CD31 (Fig. 3f ). A similar result was
obtained in human iPSC (Additional file 4: Figure S1).
Thus, optimizing the MESP1+ population percentage dur-
ing the mesoderm induction stage and co-stimulation with
S1P during the EC generation stage could markedly boost
the CD31+ EC differentiation efficiency.
Microniches dramatically improved the endothelial
differentiation efficiency and cell survival
In vivo vasculogenesis and angiogenesis occur in 3D mi-
croenvironments. Next, we tested whether a 3D scaffold
could improve endothelial differentiation from MESP1+
progenitor cells. To this end, we employed a biodegrad-
able 3D microscale scaffold, which was fabricated by
cryogelation of gelatin, and hence was called gelatin
microcryogels (GMs) [14]. These 3D GMs had an inter-
connected macroporous structure with pore sizes in the
range of 30–80 μm. They had been shown to be particu-
larly suitable for human mesenchymal stem cell (hMSC)
growth [14]. We developed a simple differentiation as
depicted in Fig. 4a. Undifferentiated hESCs were dissoci-
ated into single cells and cultured in E8 medium to
about 30% confluency. Then BMP4 and CHIR99021
were added for 3 days to induce a high percentage of
MESP1-mTomato+ cells. MESP1+ cells were then
digested to single cell suspension and loaded onto 500
tightly packed 3D GMs and incubated at 37 °C for
2 hours, during which time cells were absorbed into
GMs spontaneously. Afterwards, differentiation medium
supplemented with VEGF and bFGF was added for more
than 5 days (Fig. 4a). Culturing in 3D GMs significantly
promoted cell proliferation, from identical plating hESC
numbers (1 × 106 cells), after 15 days of differentiation,
the 3D GM group contained an average of 4.8 × 108
cells, while the conventional 2D culture group had only
1.2 × 108 cells (Fig. 4b and c). Moreover, 3D GM differ-
entiation required less frequent medium changes, only
once every 3 days, compared to daily medium changes
in 2D differentiation during a 12-day window. The quan-
tities of VEGF and bFGF growth factors used were much
smaller (Fig. 4c). Based on our calculation, about 320
million ECs could be obtained from one million input
hESCs after 15 days of differentiation in 3D, while only
17 million ECs could be obtained in 2D culture during
the same time window. Thus, the 3D GM culture ap-
peared to be significantly more cost-effective. Immuno-
staining revealed that cells formed a tubular network
strongly positive for CD31 both in 2D and 3D (Fig. 4d
and e). FACS analysis showed that, on differentiation
day 10, the 3D GMs contained 49.1 ± 5.9% CD31+ cells
while the 2D culture only had 14.1 ± 1.8% CD31+ cells.
By day 27, 86.7 ± 5.0% of cells in 3D GMs were CD31+,
while only 1.9 ± 0.5% of cells on the 2D surface were
CD31+ positive owing to overgrowth and cell death
(Fig. 4f ). Additional experiments using human iPSCs
showed similar results (Additional file 5: Figure S2). We
also performed tube formation and Ac-LDL absorption
assays using cells derived from hESC and iPSC through
the MESP1+ progenitor stage. ECs digested out from 3D
GMs after 12 days strongly expressed CD31 and VE-
cadherin (Fig. 4g). They took up Ac-LDL and could
organize into a tubular network typical of ECs (Fig. 4h and
i). Thus, 3D GMs appeared to significantly boost long-
term cell survival of ECs differentiated from MESP1+ cells.
Global gene expression analysis of MESP1+ cells
endothelial differentiation in 2D and 3D
To investigate how the 3D microenvironment influences
gene expression, we performed high-throughput RNA
sequencing of MESP1+ cells differentiated in 2D and 3D,
respectively, on day 8, as shown in Fig. 5a. A total of
2102 genes were upregulated more than 1.5-fold in 3D.
Among the top 500 genes upregulated in 3D, GO ana-
lysis showed a significant enrichment (p ≤ 0.01) of the
extracellular region, cell proliferation, cell adhesion, re-
generation, and vessel development genes (Fig. 5b and
Additional file 6: Table S4). Meanwhile, the top 500
downregulated genes in 3D were associated with the
regulation of transcription, RNA metabolism, and metal-
ion binding (Fig. 5b and Additional file 6: Table S4).
Heat maps and clusters of each GO class of upregulated
genes in 3D were generated (Additional file 5: Figure
S3). Significantly upregulated and downregulated genes
in each GO class are listed in Additional file 6: Table S4.
We performed Q-PCR analysis to validate representative
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genes upregulated in 3D, as shown Fig. 5c. Endothelial
lineage surface markers FLT1, KDR, CDH5, CD31, and
CD34, growth factors BMP7 and TGFB1, and transcrip-
tion factors ETV2, TAL1, and GATA2 all exhibited en-
hanced expression of a selection of the genes upregulated
in the RNA-seq data (Fig. 5c). These results suggested
that a 3D microenvironment might enhance EC differ-
entiation and survival from multiple aspects such as
enrichment of secreted growth factors, remodeling of cell
adhesion and extracellular matrix, and reorganization of
the cytoskeleton, which directly or indirectly affect gene
expression.
Fig. 4 3D microniche significantly improved endothelial differentiation efficiency and helped to maintain long-term cell survival. a Protocol for
endothelial differentiation from hESC in 3D microniches. b Bar graph quantification of CD31+ cell number obtained from 2D and 3D cultures on
day 15. c Cell numbers at different times and culture medium used in 2D and 3D are listed in the table (n = 3, ***p < 0.001). d Immunostaining
showing CD31 expression in 2D condition on differentiation day 10. Scale bars: 100 μm. e Immunostaining showing CD31 expression in 3D microniches
on differentiation day 10 visualized by multiphoton microscopy. Scale bars: 100 μm. f Percentage of CD31+ cells during endothelial differentiation under
2D condition and 3D microniches on day 10 and day 27 (n = 3, ***p < 0.001). g ECs differentiated from hiPSCs were immunostained with VE-cadherin
and CD31 antibodies. Scale bars: 100 μm. h and i ECs differentiated from hiPSCs in 3D GMs were digested out and tested in DiI-Ac-LDL uptake and tube
formation assay. Scale bars: 100 μm
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MESP1 progenitor cell-derived ECs enhanced vascular
repair of critical limb ischemia
To evaluate the therapeutic potential of ECs derived
from MESP1+ cells, we employed a critical limb ische-
mia (CLI) mouse model where the ischemia was induced
by ligation of the left femoral artery. After surgery, GMs
alone (control), MESP1+ cells induced with VEGF +
bFGF for 5 days (1 × 107 cells) or 3 × 105 MESP1+ cells
loaded in 3D GMs and induced with VEGF + bFGF for
5 days (Cell + GM) were injected into the ligation site
(Fig. 6a). The therapeutic efficacy of cells was examined
by evaluating the appearance and physiological status of
ischemic limbs at 0, 7, 14, 21, and 28 day after the sur-
gery. Both 1 × 107 cells alone (n = 6) and 3 × 105 cells
Fig. 5 High-throughput RNA sequencing data analysis of MESP1+ cells differentiated in 2D and 3D for 5 days. a Protocol for endothelial
differentiation and RNA-seq. b Gene ontology analysis of top 500 upregulated genes and 500 downregulated genes in 3D GMs. c Q-PCR validation of
representative endothelial marker genes enriched in 3D GM differentiation (n = 3, *p < 0.05, **p < 0.005, ***p < 0.001, 3D versus 2D; t test)
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loaded in 3D GMs (Cell + GM) salvaged the ischemia
limb within 7 days, while no limb salvage was observed
in GM only control group (n = 6) after 28 days (Fig. 6b).
The Cell + GM combination significantly reduced the
number of cells needed to salvage the CLI, since trans-
planting 3 × 105 cells alone failed to salvage the ischemic
hindlimb (data not shown). A total of 67% of mice com-
pletely recovered their legs in the Cell + GM group and
Fig. 6 Endothelial induced MESP1 progenitor cells enhanced vascular repair in critical limb ischemia mouse model. a Protocol of endothelial cell
induction and transplantation in 3D GMs. b Representative images of the hindlimb from control, free cell (107), and cell (3 × 105) induced within
microcryogels (Cell + GM) transplanted mice. Dates are indicated on the top. (n = 6 in each group). c Stacked bar graph showing the percentage
distribution of the physiological status of treated ischemic limbs on day 28 post-implantation of vehicle and Cell + GM. d The table represents the
physiological status of the ischemic limb on day 28 post-implantation of vehicle and Cell + GM. Values represent the percentage of limb salvage,
necrosis, or loss. Parametric X2 test: *p < 0.05. e Monitoring blood perfusion in ischemic hindlimb with fluorescence imaging. f Photographs
showing new blood vessel formation across ligation sites of the ischemic hindlimb 28 days after treatment
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none of them suffered from limb loss (Fig. 6c and d). In
addition, the blood flow was significantly improved by
Cell + GM or a high dose (107) of free cells (Fig. 6e). Vis-
ual inspection revealed that more blood vessels formed
across the ligation site in Cell + GM and high-dose (107)
free cell-transplanted CLI mice by day 28 (Fig. 6f ). We
also confirmed that MESP1+ cells do not have tumori-
genicity. Undifferentiated MESP1-mTomato reporter
cells formed teratoma after subcutaneous injection to
the groin region of immune-deficient mice, while differ-
entiated MESP1+ cells did not form any teratoma after
8 weeks (Additional file 5: Figure S4). Thus, MESP1 pro-
genies transplanted in 3D GMs can form functional
blood vessels in vivo and salvage the CLI mice model.
To check whether injected human cells formed blood
vessels in CLI mice, we performed immunostaining of a
frozen tissue section using anti-human CD31 antibody
and anti-human nuclei antibody. As shown in Fig. 7, no
signal was detectable in tissues from GM (Control)
transplanted mice (Fig. 7a), while numerous blood ves-
sels were labeled with human CD31 and human-specific
nuclei antibodies in tissue sections from cells or Cell +
GM transplanted mice, indicating that MESP1+ cell-
derived ECs had formed human blood vessels in CLI
mice, which are responsible for limb salvation (Fig. 7b
and c). Thus MESP1+ cell-derived ECs could be a poten-
tially useful cell source for blood vessel regeneration and
the treatment of ischemic diseases.
Discussion
In this study, we found that by optimizing the meso-
derm induction stage using MESP1-mTomato reporter
cells, we can significantly improve the efficiency of EC
generation from hESCs and iPSCs. Previous reports
mainly focused on vital functions of Mesp1 during
heart development, since it is considered the earliest
Fig. 7 Endothelial induced MESP1 progenitor cells differentiated into blood vessels in critical limb ischemia mouse. a Frozen sections from
control- treated ischemic hindlimb, no human CD31 (hCD31) and human nuclei (hNA) can be seen on day 28. Scale bar: 100 μm. b and c Frozen
sections from Cell + GM transplanted hindlimb showed clear hCD31 and hNA staining (b), and hCD31 and α-SMA co-localization (c) at day 28.
Scale bars: 100 μm
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marker of cardiovascular development in vertebrates
(Bondue and Blanpain, [11]). Our Mesp1cre/+/ROSA26-
Sortm4(ACTB-tdTomato,-EGFP)Luo lineage tracing experi-
ments in mice clearly showed that Mesp1 progenies
contributed extensively to yolk sac blood vessels, sug-
gesting that Mesp1 cells are also very amenable to tak-
ing an endothelial fate given the right induction signal.
This is further supported by our RNA-seq results:
almost all key regulators of endothelial differentiation
were upregulated in MESP1-mTomato+ cells, such as
ETV2, TAL1, GATA2, HOXA9, FOXC1, KDR, and
CXCR4. Thus, by monitoring MESP1-mTomato re-
porter, when MESP1+ cells were enriched to a high per-
centage by adjusting the concentration of BMP4 and
GSK3 inhibitor CHIR99021, we can obtain the highest
EC formation efficiency. In our hands, 1 hPSC can gen-
erate 10 MESP1 positive cells and subsequently 325.34
± 21.87 ECs after 15 days of induced differentiation.
Similar results can be obtained from human iPSCs and
other hESC lines, and thus the EC differentiation effi-
ciency positively correlated with the MESP1 expression
level during the mesoderm induction stage. Our proto-
col is also very simple. We used dissociated single
hPSCs cultured in E8 medium as the starting popula-
tion, followed by mesoderm induction by only BMP4
and CHIR99021 for 3 days. Then cells can be replated
on a 2D surface or in a 3D scaffold for EC induction
and expansion. This protocol is cost-effective and can
be modified for large-scale production.
Our RNA-seq data of MESP1+ cells provided a valu-
able resource to uncover signaling pathways that may
regulate EC differentiation. We found that S1PR3 is
specifically upregulated on MESP1+ cells. S1P is a lyso-
phospholipid mediator found in the blood which has
been shown to participate in a wide range of biological
responses, including stimulation of cell proliferation,
inhibition of apoptosis and regulation of cell shapes
and motility [20]. Biological activities of S1P are medi-
ated through the S1P receptors, a family of G protein-
coupled cell surface receptors. S1PR1, 2, and 3 triple
knock-out mice displayed abnormal bleeding and died
early during embryogenesis [21]. Mutant embryos had
an immature vascular network and the authors con-
cluded that although S1P receptors were not required
for endothelial fate specification, they play important
roles during angiogenesis [21]. Adding S1P combined
with VEGF and bFGF during stage II of the differenti-
ation significantly upregulated many key factors that
can promote EC formation, such as TAL1, CDH5, ID1,
FLT1, FOXC1, and ETV2, and, as expected, markedly
enhanced CD31+ EC generation.
In this study, we also found that growing MESP1+ cells
in 3D GMs can further boost the EC differentiation effi-
ciency. Moreover, 3D GMs can serve as an enrichment
platform, since during long-term culture ECs survived
better and 85% of cells were strongly CD31 positive after
about 4 weeks in 3D GMs. Another advantage of using a
3D GM culture is that the medium did not turn yellow
as fast as the medium used for our 2D cultures, despite
rapid cell proliferation. Hence, we only needed to change
the medium every 3 days compared to daily changes for
the 2D culture. Thus the amounts of VEGF and bFGF
required for EC differentiation and maintenance were
much smaller for our 3D culture. The RNA-seq results
revealed that many genes related to ECM, cell adhesion,
and blood vessel development were significantly upregu-
lated in 3D. The 3D GMs used in our experiments were
fabricated by cryogelation of gelatin. It had an intercon-
nected macroporous structure with pore sizes in the
range of 30–80 μm and a high ratio of porosity [14].
These 3D GMs have been shown to attract deposition of
ECM proteins and angiogenic growth factors from hu-
man mesenchymal stem cells [14]. Endothelial matrix
proteins have been shown to regulate EC sprouting, pro-
liferation, and survival [22]. In our study, multiphoton
microscopy demonstrated that 3D GM is ideal for the
formation of a tubular endothelial network. Thus, the
unique characteristics of 3D GMs may promote EC dif-
ferentiation, proliferation, and long-term survival
through both enrichment and stabilization of matrix
proteins and angiogenic cytokines and remodeling of
cell–matrix and cell–cell adhesion.
3D GM can also serve as a protective niche during
cell transplantation. Previously, adult human mesen-
chymal stem cells were loaded into the same type of 3D
GMs and injected into the CLI mouse model. Limb sal-
vation was achieved with as few as 1 × 105 cells [14]. In
our case, 67% of mice completely recovered their hind
limbs with significantly improved blood flow when only
3 × 105 MESP1+ cells were loaded into GMs. Clear
revascularization can be seen across the ligation site in
either Cell + GM transplanted or 1 × 107 free cell trans-
planted, but not in 3 × 105 free cell transplanted CLI
mice by day 28. It is likely that 3D GM prevented cell
loss during injection and after transplantation to the is-
chemic site in the animal. Interestingly, endothelial
primed MESP1+ cells formed human blood vessels at
the ligation site. Our results suggest that endothelial-
primed MESP1 mesoderm progenitor cells combined
with 3D GM could be an ideal approach to revasculate
ischemic tissues.
Conclusions
In summary, using MESP1-mTomato reporter cells, we
showed that MESP1+ mesoderm progenitor cells could
be induced to form EC at high efficiency. We also dis-
covered that S1P signaling dramatically enhanced EC
formation. Combining these findings with a tissue-
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engineering approach, we developed a simple, fast, cost-
effective, and chemically defined protocol to obtain a
high percentage of ECs in biodegradable 3D scaffolds in
vitro and demonstrated their superior therapeutic effi-
cacy in treating a CLI mouse model. Our study has
opened a new route for cell-based therapy, where
patient-specific iPSCs can be converted into MESP1+
mesoderm progenitors, then primed toward endothelial
fate to treat severe ischemia diseases.
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